Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients - Université Toulouse III - Paul Sabatier - Toulouse INP Accéder directement au contenu
Article Dans Une Revue Clinical Kidney Journal Année : 2022

Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients

Résumé

Patients with chronic kidney disease (CKD), particularly those undergoing hemodialysis (HD), are at high risk of a severe form of coronavirus disease 2019 (COVID-19). Recently we showed that an elevated neutrophil: lymphocyte ratio at day 7 of COVID-19 predicted outcome in adult HD patients. Elevated serum C reactive protein (CRP) and ferritin were also hallmarks of the disease, confirming that, similar to all COVID-19 patients, hyperinflammation and iron disorder are also present in HD patients. Here we additionally explored hepcidin, the master regulator of iron homeostasis that has rarely been measured in COVID-19 and interleukin-6 (IL-6), the cytokine that stimulates hepcidin in inflammatory conditions.
Fichier principal
Vignette du fichier
Touzot_2022.pdf (239.17 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03764736 , version 1 (30-08-2022)

Licence

Paternité

Identifiants

Citer

Maxime Touzot, Thibaud Lefebvre, Catherine Maheas, Katell Peoc'H, Pablo Ureña-Torres, et al.. Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients. Clinical Kidney Journal, 2022, 15 (3), pp.582-583. ⟨10.1093/ckj/sfab254⟩. ⟨hal-03764736⟩
20 Consultations
18 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More